151 related articles for article (PubMed ID: 9222070)
1. In-vitro and in-vivo activity of trovafloxacin against Streptococcus pneumoniae.
Klugman KP; Gootz TD
J Antimicrob Chemother; 1997 Jun; 39 Suppl B():51-5. PubMed ID: 9222070
[TBL] [Abstract][Full Text] [Related]
2. Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro.
Gootz TD; Zaniewski R; Haskell S; Schmieder B; Tankovic J; Girard D; Courvalin P; Polzer RJ
Antimicrob Agents Chemother; 1996 Dec; 40(12):2691-7. PubMed ID: 9124824
[TBL] [Abstract][Full Text] [Related]
3. Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model.
Rodoni D; Hänni F; Gerber CM; Cottagnoud M; Neftel K; Täuber MG; Cottagnoud P
Antimicrob Agents Chemother; 1999 Apr; 43(4):963-5. PubMed ID: 10103211
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of pneumococci to trovafloxacin, penicillin G, and other antimicrobial agents in the Czech Republic and Slovakia.
Urbásková P; Trupl J; Hupková H; Appelbaum PC; Jacobs MR
Eur J Clin Microbiol Infect Dis; 1996 Aug; 15(8):686-8. PubMed ID: 8894582
[TBL] [Abstract][Full Text] [Related]
5. Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
Cottagnoud P; Acosta F; Cottagnoud M; Neftel K; Täuber MG
Antimicrob Agents Chemother; 2000 Aug; 44(8):2179-81. PubMed ID: 10898696
[TBL] [Abstract][Full Text] [Related]
6. Activity of trovafloxacin against blood isolates of Streptococcus pneumoniae in Sweden.
Liljequist BO; Hoffman BM; Hedlund J
Eur J Clin Microbiol Infect Dis; 1996 Aug; 15(8):671-5. PubMed ID: 8894578
[TBL] [Abstract][Full Text] [Related]
7. Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology.
Visalli MA; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 1996 Jan; 37(1):77-84. PubMed ID: 8647777
[TBL] [Abstract][Full Text] [Related]
8. Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae.
Kim YS; Liu Q; Chow LL; Täuber MG
Antimicrob Agents Chemother; 1997 May; 41(5):1186-9. PubMed ID: 9145898
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of trovafloxacin against penicillin-susceptible and multiresistant strains of Streptococcus pneumoniae in a mouse pneumonia model.
Bédos JP; Rieux V; Bauchet J; Muffat-Joly M; Carbon C; Azoulay-Dupuis E
Antimicrob Agents Chemother; 1998 Apr; 42(4):862-7. PubMed ID: 9559797
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of trovafloxacin, ciprofloxacin and ampicillin against Streptococcus pneumoniae in a murine sepsis model.
Lacy MK; Nicolau DP; Banevicius MA; Nightingale CH; Quintiliani R
J Antimicrob Chemother; 1999 Oct; 44(4):477-81. PubMed ID: 10588309
[TBL] [Abstract][Full Text] [Related]
11. Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents.
Hoellman DB; Lin G; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 1999 May; 43(5):645-9. PubMed ID: 10382885
[TBL] [Abstract][Full Text] [Related]
12. Comparative antimicrobial activity of trovafloxacin tested against 3049 Streptococcus pneumoniae isolates from the 1997-1998 respiratory infection season.
Jones RN; Pfaller MA; Doern GV
Diagn Microbiol Infect Dis; 1998 Oct; 32(2):119-26. PubMed ID: 9823536
[TBL] [Abstract][Full Text] [Related]
13. Gemifloxacin is efficacious against penicillin-resistant and quinolone-resistant pneumococci in experimental meningitis.
Cottagnoud P; Acosta F; Cottagnoud M; Täuber MG
Antimicrob Agents Chemother; 2002 May; 46(5):1607-9. PubMed ID: 11959614
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility to gemifloxacin and trovafloxacin of Streptococcus pneumoniae strains exhibiting decreased susceptibility to ciprofloxacin.
Fuentes F; Giménez MJ; Marco F; Alou L; Aguilar L; Prieto J
Eur J Clin Microbiol Infect Dis; 2000 Feb; 19(2):137-9. PubMed ID: 10746503
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics of trovafloxacin in experimental pneumococcal meningitis: basis for dosage selection in children with meningitis.
McCoig CC; Wubbel L; Jafri HS; Lutsar I; Bastero R; Olsen K; Shelton S; Friedland IR; McCracken GH
J Antimicrob Chemother; 1999 May; 43(5):683-8. PubMed ID: 10382890
[TBL] [Abstract][Full Text] [Related]
16. Trovafloxacin, a new fluoroquinolone with potent activity against Streptococcus pneumoniae.
Thomson KS; Chartrand SA; Sanders CC; Block SL
Antimicrob Agents Chemother; 1997 Feb; 41(2):478-80. PubMed ID: 9021213
[TBL] [Abstract][Full Text] [Related]
17. In-vitro activity of the fluoroquinolone trovafloxacin against penicillin-susceptible and -resistant Streptococcus pneumoniae.
Klugman K; Wasas A
J Antimicrob Chemother; 1995 Nov; 36(5):873-4. PubMed ID: 8626270
[No Abstract] [Full Text] [Related]
18. Pharmacodynamics of trovafloxacin in a mouse model of cephalosporin-resistant Streptococcus pneumoniae pneumonia.
Ng W; Lutsar I; Wubbel L; Ghaffar F; Jafri H; McCracken GH; Friedland IR
J Antimicrob Chemother; 1999 Jun; 43(6):811-6. PubMed ID: 10404320
[TBL] [Abstract][Full Text] [Related]
19. Determining the frequency of resistance of Streptococcus pneumoniae to ciprofloxacin, levofloxacin, trovafloxacin, grepafloxacin, and gemifloxacin.
Evans ME
Eur J Clin Microbiol Infect Dis; 2001 Dec; 20(12):883-5. PubMed ID: 11837640
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and pharmacodynamics of simulated human-like treatment with levofloxacin on experimental pneumonia induced with penicillin-resistant pneumococci with various susceptibilities to fluoroquinolones.
Croisier D; Chavanet P; Lequeu C; Ahanou A; Nierlich A; Neuwirth C; Piroth L; Duong M; Buisson M; Portier H
J Antimicrob Chemother; 2002 Sep; 50(3):349-60. PubMed ID: 12205059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]